Paul J. Silver

3.0k total citations
101 papers, 2.4k citations indexed

About

Paul J. Silver is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Paul J. Silver has authored 101 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 46 papers in Cardiology and Cardiovascular Medicine and 29 papers in Physiology. Recurrent topics in Paul J. Silver's work include Nitric Oxide and Endothelin Effects (26 papers), Phosphodiesterase function and regulation (25 papers) and Cardiomyopathy and Myosin Studies (15 papers). Paul J. Silver is often cited by papers focused on Nitric Oxide and Endothelin Effects (26 papers), Phosphodiesterase function and regulation (25 papers) and Cardiomyopathy and Myosin Studies (15 papers). Paul J. Silver collaborates with scholars based in United States, Canada and Germany. Paul J. Silver's co-authors include James T. Stull, J. DiSalvo, Alex L. Harris, Edward D. Pagani, L T Hamel, Ross Bentley, David J. Triggle, Ronald A. Janis, Dale B. Evans and Richard Buchholz and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Paul J. Silver

99 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul J. Silver United States	25	1.4k	878	691	337	283	101	2.4k
E. J. Cragoe United States	31	1.8k 1.2×	340 0.4×	437 0.6×	446 1.3×	234 0.8×	77	2.7k
Matthias Schramm Germany	26	2.0k 1.4×	1.0k 1.2×	1.3k 1.8×	809 2.4×	229 0.8×	45	3.6k
Chandra K. Mittal United States	18	1.1k 0.7×	653 0.7×	1.8k 2.6×	409 1.2×	292 1.0×	32	3.0k
William L. Rumsey United States	26	1.5k 1.0×	320 0.4×	675 1.0×	164 0.5×	328 1.2×	62	3.3k
Raymond J. Winquist United States	27	1.4k 1.0×	1.2k 1.4×	796 1.2×	476 1.4×	69 0.2×	69	2.9k
Johannes-Peter Stasch Germany	22	1.0k 0.7×	918 1.0×	1.3k 1.9×	130 0.4×	278 1.0×	31	2.7k
Annie Beuve United States	28	1.4k 1.0×	721 0.8×	1.2k 1.7×	193 0.6×	333 1.2×	60	2.6k
Ronald R. Fiscus United States	31	1.2k 0.9×	369 0.4×	802 1.2×	575 1.7×	122 0.4×	84	2.6k
Shoji Katsuki Japan	10	947 0.7×	648 0.7×	1.6k 2.4×	421 1.2×	195 0.7×	22	2.7k
Emil Martin United States	27	1.2k 0.8×	367 0.4×	1.2k 1.8×	149 0.4×	454 1.6×	51	2.7k

Countries citing papers authored by Paul J. Silver

Since Specialization

Citations

This map shows the geographic impact of Paul J. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Silver more than expected).

Fields of papers citing papers by Paul J. Silver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Silver. The network helps show where Paul J. Silver may publish in the future.

Co-authorship network of co-authors of Paul J. Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Silver. A scholar is included among the top collaborators of Paul J. Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Silver. Paul J. Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parkman, Henry P., Katherine P. Yates, Irene Sarosiek, et al.. (2023). Buspirone for early satiety and symptoms of gastroparesis: A multi‐centre, randomised, placebo‐controlled, double‐masked trial ( BESST ). Alimentary Pharmacology & Therapeutics. 57(11). 1272–1289. 14 indexed citations

Lee, Susie, et al.. (2023). Health-Related Social Needs in Patients With Gastroparesis: Relationships to Symptom Severity and Quality of Life. SHILAP Revista de lepidopterología. 3(1). 48–54.

Denholm, Elizabeth M., Yongqing Lin, & Paul J. Silver. (2001). Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion. European Journal of Pharmacology. 416(3). 213–221. 82 indexed citations

Watts, Stephanie W., Gregory D. Fink, Paul J. Silver, & Daniel J. Cushing. (2000). Interaction of the β Adrenergic Receptor Antagonist Bucindolol with Serotonergic Receptors. Journal of Cardiovascular Pharmacology. 35(1). 29–36. 5 indexed citations

Bacon, Edward R., et al.. (1994). Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.. PubMed. 24(3). 403–10. 3 indexed citations

Dolle, Roland E., Joseph A. Dunn, Mark A. Bobko, et al.. (1994). 5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase. Journal of Medicinal Chemistry. 37(17). 2627–2629. 36 indexed citations

Dundore, Ronald L., et al.. (1993). Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. European Journal of Pharmacology. 249(3). 293–297. 56 indexed citations

Pagani, Edward D., et al.. (1993). Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast. European Journal of Pharmacology. 243(2). 141–147. 25 indexed citations

Silver, Paul J., et al.. (1992). Vascular protein kinase C in Wistar-Kyoto and spontaneously hypertensive rats. European Journal of Pharmacology. 212(2-3). 143–149. 13 indexed citations

10.

Silver, Paul J., et al.. (1991). Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 382–391. 22 indexed citations

11.

Buchholz, Richard, Ronald L. Dundore, & Paul J. Silver. (1991). Hemodynamic Response of Conscious Rats and Dogs to the Protein Kinase C Inhibitor Staurosporine. Advances in experimental medicine and biology. 308. 199–204. 2 indexed citations

12.

Dundore, Ronald L., Paul J. Silver, Alan M. Ezrin, et al.. (1991). The Effects of Iodixanol and Iopamidol on Hemodynamic and Cardiac Electrophysiologic Parameters In Vitro and In Vivo. Investigative Radiology. 26(8). 715–721. 17 indexed citations

13.

Silver, Paul J., et al.. (1990). Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine. Journal of Cardiovascular Pharmacology. 16(3). 501–505. 22 indexed citations

14.

Silver, Paul J., et al.. (1989). Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents. Cardiovascular Drugs and Therapy. 3(5). 675–682. 15 indexed citations

15.

Silver, Paul J., Richard L. Fenichel, & Robert L. Wendt. (1988). Structural Variants of Verapamil and W-7 with Combined Ca2+ Entry Blockade/Myosin Phosphorylation Inhibitory Mechanisms. Journal of Cardiovascular Pharmacology. 11(3). 299–307. 6 indexed citations

16.

Silver, Paul J. & P Monteforte. (1988). Differential effects of pharmacological modulators of cardiac myofibrillar ATPase activity in normal and myopathic (BIO 14.6) hamsters. European Journal of Pharmacology. 147(3). 335–342. 5 indexed citations

17.

Janis, Ronald A., Paul J. Silver, & David J. Triggle. (1987). Drug action and cellular calcium regulation. 16. 309–591. 164 indexed citations

18.

Silver, Paul J.. (1986). Pharmacological Modulation of Cardiac and Vascular Contractile Protein Function. Journal of Cardiovascular Pharmacology. 8. S30–46. 14 indexed citations

19.

Silver, Paul J.. (1986). Pharmacological Modulation of Cardiac and Vascular Contractile Protein Function. Journal of Cardiovascular Pharmacology. 8. S30–46. 4 indexed citations

20.

Silver, Paul J. & James T. Stull. (1983). Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.. Molecular Pharmacology. 23(3). 665–670. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact